Relevant bibliographies by topics / Chronic obstructive pulmonary disease patients

Academic literature on the topic 'Chronic obstructive pulmonary disease patients'

Author: Grafiati
Published: 4 June 2021
Last updated: 20 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Chronic obstructive pulmonary disease patients.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Chronic obstructive pulmonary disease patients"

1

Alotaibi, Fayez Salem Marzoq, Wafa Jazi Alhamereen, Saosan Abdulrahman Almogisib, Ohoud Jazi Alhamereen, Tahani Mohammed Alanazi, Safa Diab Alokaili, Awad Lafi Almutairi, Sultan M. Abuqayyan, and Yahya Mohammed alzain. "Assessment of Depression and Smoking in Chronic Obstructive Pulmonary Disease Patients." International Journal Of Pharmaceutical And Bio-Medical Science 02, no. 11 (November 30, 2022): 557–60. http://dx.doi.org/10.47191/ijpbms/v2-i11-15.

Full text
Abstract:
Background: Depression is common in COPD patients, and smokers are more likely to develop it. Methods: The smoking habits of 100 people with COPD were evaluated for the study during either an outpatient visit or a hospital stay. The Hamilton depression rating scale was used to assess depression in the study population (HAM-D). Result: The majority of the COPD patients in the current study were former smokers. The findings indicated that former smokers were more likely to experience depressed symptoms. Conclusion: Depression is a common condition among COPD patients. The findings revealed that patient age and smoking habits had a significant impact on the progression of COPD illness.
APA, Harvard, Vancouver, ISO, and other styles
2

Uryasev, O. M., S. V. Faletrova, and L. V. Korshunova. "Combination of asthma and chronic obstructive pulmonary disease: features of etiology, pathogenesis, diagnosis, pharmacotherapy." Kazan medical journal 97, no. 3 (June 15, 2016): 394–400. http://dx.doi.org/10.17750/kmj2016-394.

Full text
Abstract:
Bronchial asthma and chronic obstructive pulmonary disease are the most common obstructive diseases of the respiratory system. 230 million people suffer from chronic obstructive pulmonary disease, from bronchial asthma - 300 million people worldwide. Annually 200-300 people in Europe and 2.74 million of world population die from chronic obstructive pulmonary disease, from asthma - 250 thousand people a year. The social and economic significance of these diseases determine the need for in-depth study of their combination in the same patient. Each disease has its own phenotypes, but in 10-20% of patients, there are symptoms of both chronic obstructive pulmonary disease and asthma. In spite of clear diagnostic criteria, in some cases it is difficult to distinguish these diseases. Morphological basis of these diseases is a chronic inflammation in the bronchial tree that causes damage to the epithelial continuity that initiates bronchoconstrictive reaction and leads to irreversible airway obstruction attributable for both severe bronchial obstruction and chronic obstructive pulmonary disease. However, the treatment strategy of bronchial asthma and chronic obstructive pulmonary disease has significant differences, it is important to have a clear diagnostic criteria to distinguish different phenotypes, including those of combined phenotype of asthma and chronic obstructive pulmonary disease. Rational starting therapy of asthma and chronic obstructive pulmonary disease overlap syndrome includes drugs acting on the pathogenic mechanisms of both diseases, and is a combination of inhaled corticosteroids with combined bronchodilator therapy - long-acting β2-agonists and long-acting anticholinergics.
APA, Harvard, Vancouver, ISO, and other styles
3

Preveden, Andrej, Mirko Todic, Vanja Drljevic-Todic, Mihaela Preveden, Ranko Zdravkovic, and Biljana Zvezdin. "Use of beta blockers in patients with asthma and chronic obstructive pulmonary disease." Medical review 74, no. 3-4 (2021): 127–33. http://dx.doi.org/10.2298/mpns2104129p.

Full text
Abstract:
Introduction. Beta blockers play an essential role in the treatment of cardiovascular diseases, but also various other endocrinological, gastroenterological, ophthalmological and neurological disorders. The most important effects of beta blockers are a reduction in myocardial oxygen consumption and inhibition of renin secretion. Beta blockers are divided into three generations according to their selectivity - non-selective, cardioselective and vasodilating beta blockers. Beta blockers and obstructive pulmonary diseases. Patients with obstructive pulmonary diseases are significantly more likely to develop cardiovascular diseases compared to general population, largely due to common risk factors such as smoking, systemic inflammation, age, and genetic predisposition. The use of nonselective beta blockers carries a great risk for patients with obstructive pulmonary diseases, while cardioselective beta blockers can be used more extensively. Reversible airway obstruction is predominantly present in asthma, so that the adverse effects of beta blockers on the airways are significantly more pronounced in asthma compared to chronic obstructive pulmonary disease. Conclusion. In both asthma and chronic obstructive pulmonary disease, the use of highly cardioselective beta blockers such as bisoprolol and nebivolol is preferred. The use of beta blockers in patients with asthma requires great caution due to the possibility of bronchial obstruction, while in patients with chronic obstructive pulmonary disease they are somewhat safer. Patients must be closely monitored by a physician, with special attention focused on clinical signs of airway obstruction such as wheezing, shortness of breath, and prolonged expiration.
APA, Harvard, Vancouver, ISO, and other styles
4

Rasputina, Lesya, and Daria Didenko. "PREVALENCE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN PATIENTS WITH CORONARY HEART DISEASE AND ARTERIAL HYPERTENSION." EUREKA: Health Sciences 2 (March 31, 2017): 38–45. http://dx.doi.org/10.21303/2504-5679.2017.00320.

Full text
Abstract:
The prevalence of chronic obstructive pulmonary disease among patients with cardio-vascular diseases is higher than in general population. At the same time the one of problems of internal medicine is a timely diagnostics of chronic obstructive pulmonary disease. The aim of the work was the study of prevalence of chronic obstructive pulmonary disease among patients with cardio-vascular diseases, especially arterial hypertension and coronary heart disease. Materials and methods. The retrospective analysis of statistical cards of patients, who were on stationary treatment at therapeutic departments, was carried out to estimate the prevalence of combination of chronic obstructive pulmonary disease with arterial hypertension. The target examination of 136 patients was realized for revelation of chronic obstructive pulmonary disease. All patients were interrogated by the original modified questionnaire of assessment of short breath by medical research council (mMRC), test for assessment of chronic obstructive pulmonary disease (CAT) and underwent spirography with bronchodilatation test. Results. It was established, that 10,2 % of patients had the combination of chronic obstructive pulmonary disease with arterial hypertension. Among persons, who were on treatment as to the stable coronary heart disease and had not obstructive disease of respiratory organs in anamnesis, in 26,4 % the chronic obstructive pulmonary disease was diagnosed for the first time.
APA, Harvard, Vancouver, ISO, and other styles
5

Sijapati, Milesh Jung, Narayan Bikram Thapa, Rajendra Rijal, Shiva Raj KC, and Poojyashree Karki. "Bronchiectasis in patients with chronic obstructive pulmonary disease." Journal of Pathology of Nepal 8, no. 2 (September 6, 2018): 1346–49. http://dx.doi.org/10.3126/jpn.v8i2.20870.

Full text
Abstract:
Background: Chronic obstructive pulmonary disease is most common disease entity and third leading cause of mortality worldwide. The presence of bronchiectasis in severe chronic obstructive pulmonary disease patients had led to frequent exacerbation requiring hospitalizations. The purpose of this study was to identify the factors associated with bronchiectasis, using routine data collected during medical visits from patients diagnosed with chronic obstructive pulmonary disease.Materials and Methods: This is hospital based cross sectional study conducted on 120 chronic obstructive pulmonary disease patients. All patients were subjected through history, examination, pulmonary function test, sputum samples and imaging of chest.Results: Out of 120 patients among them 67 patients (55.8%) were chronic obstructive pulmonary disease without bronchiectasis while 53 patients (44.1%) had chronic obstructive pulmonary disease with bronchiectasis. Thirty patients (56.6%) having chronic obstructive pulmonary disease with bronchiectasis and 18 patient (26.8%) having chronic obstructive pulmonary disease without bronchiectasis had exacerbation in one year requiring hospitalisation. Most common organisms isolated were Pseudomonas Aeruginosa in 20 patients (55.5%), Klebsillae Pneumoniae in 6 patients (16.6%) among chronic obstructive pulmonary disease with bronchiectasis group.Conclusion: Chronic obstructive pulmonary disease patient with severe airflow limitation, with frequent exacerbation and colonisation with isolation of organisms resulting in bronchiectasis requiring frequent hospitalisation.
APA, Harvard, Vancouver, ISO, and other styles
6

Shrestha, Ashis, and Sumana Bajrachraya. "Spirometry Findings in Patients with Chronic Obstructive Pulmonary Disease." Journal of Patan Academy of Health Sciences 1, no. 1 (July 20, 2015): 33–35. http://dx.doi.org/10.3126/jpahs.v1i1.13014.

Full text
Abstract:
Introductions: Clinical diagnosis of chronic obstructive pulmonary disease is often not accurate and treated for prolong duration. This study explores the use of pulmonary function test to confirm the diagnosis and further management of such patients. Methods: This was a cross sectional study conducted at Patan Hospital, Patan Academy of Health Sciences, Nepal. All patients coming for spirometry between June 2012 and May 2013 with the clinical diagnosis of chronic obstructive pulmonary disease were enrolled in the study. Results: Out of 338 patients with clinical diagnosis of chronic obstructive pulmonary disease that underwent spirometry, 80 (23.7%) patients had ratio of forced expiratory volume in one second and forced vital capacity less than 70%. Out of these 80 patients, 50 (14.8%) had irreversible airway obstruction and 30 (8.9%) had reversible airway obstruction. Patient with normal spirometry findings was 258(76.3%). Conclusions: Clinically diagnosed chronic obstructive pulmonary disease is best confirmed by spirometry for optimum management. Plain Language Summary: The study was done to see whether the clinical diagnosis of COPD is accurate of not. The study found that most of the patient diagnosed as COPD did not have the disease on spirometry. So, diagnosis of COPD should always be aided by spirometry before starting long term treatment. DOI: http://dx.doi.org/10.3126/jpahs.v1i1.13014 Journal of Patan Academy of Health Sciences. 2014 Jun;1(1):33-35
APA, Harvard, Vancouver, ISO, and other styles
7

Helena, González. "Body Composition, Functional Status and Clinical Outcomes in Patients with Chronic Obstructive Pulmonary Disease." Biomedical Research and Clinical Reviews 2, no. 1 (December 24, 2020): 01–06. http://dx.doi.org/10.31579/2692-9406/025.

Full text
Abstract:
Objective: To define the correlation between the Fat Free Mass Index (FFMI), the muscle function, degree of airflow obstruction, the respiratory symptoms and the number of exacerbations during the last year in patients with Chronic Obstructive Pulmonary Disease (COPD). Methods: Prospective and cross-sectional study of subjects older than 40 years with a clinical diagnosis of COPD who underwent measurement of the FFMI and muscular function to determine if these were correlated with the variables of severe COPD. Results: 55 patients Participated in the study. The FFMI was below 32.7% (n=18) and the strength diminished in 56.4% (n=31). In the sample, we found a direct and significant correlation between the FFMI and the FEV1* (predicted %), (p= 0,045). When analyzed by sex, men had a direct correlation between FFMI and the FEV1*(predicted %), (p=0,019), an inverse correlation between FFMI and the spirometric classification of the Global Initiative Obstructive Lung Disease (GOLD) (p=0,008) and between the muscular function and the symptoms (p=0, 03). In women no significant correlation was found. Conclusions: The conditions in mass and the muscular function were correlated with clinical variables and pulmonary function in men, but not in women. We did not find a correlation between corporal composition and the number of exacerbations.
APA, Harvard, Vancouver, ISO, and other styles
8

Lazovic, Biljana, Mirjana Zlatkovic-Svenda, Sanja Mazic, Zoran Stajic, and Marina Djelic. "Analysis of electrocardiogram in chronic obstructive pulmonary disease patients." Medical review 66, no. 3-4 (2013): 126–29. http://dx.doi.org/10.2298/mpns1304126l.

Full text
Abstract:
Introduction. Chronic obstructive pulmonary disease is the fourth leading cause of mortality worldwide. It is defined as a persistent airflow limitation usually progressive and not fully reversible to treatment. The diagnosis of chronic obstructive pulmonary disease and severity of disease is confirmed by spirometry. Chronic obstructive pulmonary disease produces electrical changes in the heart which shows characteristic electrocardiogram pattern. The aim of this study was to observe and evaluate diagnostic values of electrocardiogram changes in chronic obstructive pulmonary disease patients with no other comorbidity. Material and Methods. We analyzed 110 electrocardiogram findings in clinically stable chronic obstructive pulmonary disease patients and evaluated the forced expiratory volume in the first second, ratio of forces expiratory volume in the first second to the fixed vital capacity, chest radiographs and electrocardiogram changes such as p wave height, QRS axis and voltage, right bundle branch block, left bundle branch block, right ventricular hypertrophy, T wave inversion in leads V1-V3, S1S2S3 syndrome, transition zone in praecordial lead and QT interval. Results. We found electrocardiogram changes in 64% patients, while 36% had normal electrocardiogram. The most frequent electrocardiogram changes observed were transition zone (76.36%) low QRS (50%) and p pulmonale (14.54%). Left axis deviation was observed in 27.27% patients. Conclusion. Diagnostic values of electrocardiogram in patients with chronic obstructive pulmonary disease suggest that chronic obstructive pulmonary disease patients should be screened electrocardiographically in addition to other clinical investigations.
APA, Harvard, Vancouver, ISO, and other styles
9

Hayat, Atif Sitwat, Abdul Haque Khan, Ghulam Nabi Pathan, and Mohammad Zubair Mushtaque. "CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)." Professional Medical Journal 23, no. 09 (September 10, 2016): 1073–78. http://dx.doi.org/10.29309/tpmj/2016.23.09.1701.

Full text
Abstract:
Objectives: Chronic obstructive pulmonary disease (COPD) leads to partialreversible obstruction of airways. The objective of our study is to determine frequency ofelevated C-reactive protein (CRP) level in patients of COPD at Liaquat University HospitalJamshoro/Hyderabad. Study Design: Cross-sectional study. Setting: Medical Unit-I of LiaquatUniversity Hospital Jamshoro/Hyderabad. Period: 1st March 2013 to 31st August 2013. Patientsand Methods: Patients of either sex and ages from 40-80 years old and having COPD for atleast two years duration were included. Patients below 40 years of age, having malignanciesor autoimmune disorders were excluded from this study. Results: We enrolled 186 patientswith COPD and their mean age was ± SD 57.63±8.45 years. Majority 182 (97.8%) had habitof smoking while 4(2.2%) were non-smokers. Mean CRP level in COPD patients was ± SD1.26±0.79 (range 0.1- 3.0 mg/d1). Out of 186 COPD patients, 94(50.6%) have raised CRP level(higher than 1.0 mg/dl). Median value of CRP level during this study was 1.10 mg/dl. About92(49.4%) patients have normal level of CRP (less than 1.0 mg/dl). Conclusion: On conclusion,frequency of raised C-reactive protein in our study was much higher (50.6%).
APA, Harvard, Vancouver, ISO, and other styles
10

Gupta, Nidhi, Gajendra Dubey, Citralekha Vora, Tarun Madan, Pankaj Garg, and Usha Patel. "Cardiac Co-morbidities in Patients with Chronic Obstructive Pulmonary Disease: Prospective Observational Study." Journal of Cardiovascular Medicine and Surgery 4, no. 2 (2018): 108–13. http://dx.doi.org/10.21088/jcms.2454.7123.4218.6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Chronic obstructive pulmonary disease patients"

1

Domenech, Pena Arnau. "Dynamics of Streptococcus pneumoniae in patients with Chronic Obstructive Pulmonary Disease." Doctoral thesis, Universitat de Barcelona, 2013. http://hdl.handle.net/10803/134277.

Full text
Abstract:
It is estimated that within a few years chronic obstructive pulmonary disease (COPD) will be the third leading cause of death worldwide. The morbidity and mortality associated with COPD are due, in part to acute exacerbation episodes (AECOPD), mainly caused by microbial pathogens such as Haemophilus influenzae, Streptococcus pneumoniae and Pseudomonas aeruginosa. Moreover, COPD is the main underlying disease associated with pneumococcal pneumonia episodes. This thesis describes four studies performed to gain insights into the role of pneumococci and their closely-related species S. pseudopneumoniae in causing acute exacerbation and pneumonia episodes in COPD patients. In the first study, a total of 188 sputum samples were obtained from AECOPD episodes occurring in severe COPD patients during a 1-year period. Samples were quantitatively cultured; of them, S. pneumoniae was isolated in 31 (16.5%) episodes and S. pseudopneumoniae in 9 (4.8%) episodes. S. pneumoniae was the third most frequent cause after Pseudomonas aeruginosa (28.8%) and Haemophilus influenzae (19.7%). There are major differences in the invasiveness potential of pneumococci, depending on their serotype and genotype. Indeed, in our second study (from 2001 to 2008) we found an association of certain serotypes, and their related genotypes, with different pneumococcal infections. Serotypes 4 (ST2474), 5 (Colombia5-ST289) and 8 (Netherlands8-ST53) were associated with bacteraemic pneumonia, serotypes 1 (Sweden1-ST306) and 3 (Netherlands3-ST180 and ST2603) with bacteraemic and non-bacteraemic pneumonia, and serotypes 16F (ST3016F), 11A and non-typeable pneumococci with AECOPD episodes (P<0.05). Finally, in our experience, serotype 3 pneumococcus was the most frequent cause of pneumonia and acute exacerbations in COPD patients. Moreover, the implementation of pneumococcal conjugate vaccine PCV7 for children in 2001 in Spain has been shown to be highly effective in reducing invasive pneumococcal disease in children, and in adults as well due to the phenomenon of herd protection. This effect was also observed among pneumococci causing acute exacerbations in adults: PCV7 serotypes decreased from 39.4% in the 2001-04 period to 11.2% in the 2009-12 period. In parallel, the prevalence of multi-drug resistant serotypes 15A and 6C has dramatically increased in recent years. For this reason, although the resistance rates of β-lactams decreased over time, macrolides and multi-drug resistance remained stable throughout the study period. The presence of bacteria colonizing the lower airways of most severe COPD patients results in bronchial epithelial injury and increases morbidity among these patients. In the third study (1995-2010 period), it was found that a third of recurrent pneumococcal acute exacerbations were relapses (caused by a pre-existing strain), mainly associated with serotypes 9V and 19F (P<0.02). This suggests an important role for capsular type in pneumococcal persistence. In view of these results, we analysed the impact of antimicrobial consumption in the development of pneumococcal resistance to β-lactams and fluoroquinolones in 13 patients with a long-time persistence of pneumococci (average time: 582 days, SD ±362). Changes in quinolone-resistant determining regions (QRDR) involved in fluoroquinolone resistance were frequently observed in persistent strains after fluoroquinolone treatment; however, the penicillin-binding protein (PBP) sequences were stable over time, even though all but two patients received multiple courses of β-lactam treatment. These results suggest that an optimal combination of pbp genes is maintained to compensate for the fitness cost imposed by additional changes in these genes. Despite the genetic stability of these persistent strains, S. pneumoniae is naturally transformable and is able to acquire exogenous DNA, resulting in a dynamic and complex epidemiology of pneumococcal diseases. This genetic diversity was also observed among the 36 S. pseudopneumoniae strains analysed. Altogether, our studies can help to improve the understanding of the dynamics of S. pneumoniae and S. pseudopneumoniae populations causing disease in COPD patients.
En aquesta tesis, es van dur a terme quatre estudis amb l’objectiu d’aprofundir en el paper de S. pneumoniae com a causant d’exacerbacions agudes i pneumònia en pacients amb MPOC. En el primer estudi, es van sembrar quantitativament un total de 188 mostres d’esput obtingudes durant episodis d’EAMPOC en pacients amb MPOC avançat, durant un any d’estudi (febrer 2010 - febrer 2011). S. pneumoniae es va aïllar en 31 (16.5%) episodis i fou la tercera causa d’exacerbació, després de Pseudomonas aeruginosa (28.8%) i Haemophilus influenzae (19.7%). En el segon estudi es va trobar una diferent associació d’alguns serotipus i del seus genotipus relacionats, en pacients amb MPOC amb diferents infeccions pneumocòcciques (període 2001-2008). El serotipus 3 va ser la causa més freqüent de pneumònia i d’EAMPOC, però els serotipus 4 (ST2474), 5 (Colombia5-ST289) i 8 (Netherlands8-ST53) es varen associar amb pneumònia bacterièmica; serotipus 1 (Sweden1-ST306) i 3 (Netherlands3-ST180 i ST2603) es varen associar amb pneumònia tant bacterièmica com no bacterièmica; mentre serotipus 16F (ST3016F), 11A i els pneumococs no-tipificables es varen associar amb EAMPOC (P<0.05). Degut a la implementació de la vacuna conjugada PCV7, els serotipus inclosos en la vacuna han disminuït del 39.4% en el període 2001-2004 a 11.2% en el període 2008-2012. Paral•lelament a aquest descens, els serotipus 15A i 6C han augmentat dramàticament en els últims anys. Per aquesta raó, la multiresistència s’ha mantingut estable durant tot el període d’estudi. En el tercer estudi (1995-2010), es va observar que un terç dels episodis d’EAMPOC recurrents, varen ser causats per una soca preexistent, principalment serotipus 9V i 19F (P<0.05), considerant-se recaigudes. Aquest fet suggereix un paper important del tipus capsular en la persistència. Finalment, es va analitzar l’impacte del consum d’antimicrobians en el desenvolupament de resistència en 13 pacients colonitzats per pneumococc (temps mitjà: 582 dies, DS ±362). Es van observar canvis en les QRDRs de les soques d’aquells pacients que van rebre tractament amb fluoroquinolones. En canvi, les PBPs de les soques persistents van romandre estables tot i els múltiples tractaments amb β-lactàmics que van rebre els pacients. En total, els estudis presentats han millorat el coneixement de la dinàmica de les poblacions de S. pneumoniae i S. pseudopneumoniae en pacients amb MPOC.
APA, Harvard, Vancouver, ISO, and other styles
2

Correll, Amanda Leigh. "Strength training in patients with chronic obstructive pulmonary disease." Winston-Salem, NC : Wake Forest University, 2009. http://dspace.zsr.wfu.edu/jspui/handle/10339/42574.

Full text
Abstract:
Thesis (M.S.)--Wake Forest University. Dept. of Health and Exercise Science, 2009.
Title from electronic thesis title page. Thesis advisor: Michael J. Berry. Includes bibliographical references (p. 49-54).
APA, Harvard, Vancouver, ISO, and other styles
3

Roberts, Della Kim. "The family experience with chronic obstructive pulmonary disease." Thesis, University of British Columbia, 1985. http://hdl.handle.net/2429/24422.

Full text
Abstract:
This study was designed to gain an understanding of the family experience when an adult member has chronic obstructive pulmonary disease (COPD). It is recognized that illness within the family affects the well-being of the family unit and the health of all members. To understand the impact of COPD upon the family, however, the literature provides only knowledge of the experience of the individual who has COPD and the spouse, not that of the family unit. Thus, the purpose of this study was to describe and explain the COPD experience from the perspective of the family unit. A qualitative method, phenomenology, was chosen for this investigation. Data were collected through semi-structured interviews with eight families who shared their experiences. From the content analysis of these data, three themes that were common throughout the families' accounts were identified and developed to describe and explain family life with COPD. The first theme, disease-dictated family life, describes four aspects of a common lifestyle that is imposed on the family by the characteristics of COPD. The second theme, isolation, describes the isolation that accompanies the illness experience, for the family group and the individual members within the group. The final theme, family work, describes the four primary challenges the families face and the coping strategies they use to deal with them. These findings revealed that COPD acts as an intense stressor within the family, requiring extensive family work to cope with COPD in a way that maintains the well-being of the family unit. Furthermore, it was found that living with COPD in many ways inhibits the resources within the family and those external sources of support that foster the family's ability to manage the stress associated with living with COPD. The implications for nursing practice and nursing research were delineated in light of the research findings.
Applied Science, Faculty of
Nursing, School of
Graduate
APA, Harvard, Vancouver, ISO, and other styles
4

Bestall, Janine Caroline. "Outcome of pulmonary rehabilitation in patients with severe chronic obstructive pulmonary disease." Thesis, Queen Mary, University of London, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.322237.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Wadell, Karin. "Physical training in patients with chronic obstructive pulmonary disease - COPD." Doctoral thesis, Umeå : Univ, 2004. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-363.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Koreny, Maria 1972. "Determinants of physical activity behaviour in patients with chronic obstructive pulmonary disease." Doctoral thesis, TDX (Tesis Doctorals en Xarxa), 2021. http://hdl.handle.net/10803/671432.

Full text
Abstract:
Background: Although physical activity is key to improve prognosis in patients with chronic obstructive pulmonary disease (COPD), information to tailor interventions individually is still required. This thesis aims to understand physical activity progression and explore its determinants in COPD patients. Methods: We used baseline and 12-month data from 643 COPD patients with stable mild-to very severe disease from two European multicenter studies. We assessed: physical activity (Dynaport MoveMonitor), physical activity experience (Clinical visit-PROactive physical activity in COPD [C-PPAC]), functional exercise capacity (6-minutes walk distance [6MWD]), as well as sociodemographic, interpersonal, environmental, clinical and psychological variables. Results: (1) The natural progression in physical activity over time was heterogeneous and three distinct patterns could be identified: Inactive, Active Improvers and Active Decliners. While Inactive patients related to worse scores for clinical COPD characteristics, Active Improvers and Decliners could not be predicted at baseline; (2) Higher population density and long-term NO2 exposure were associated with lower physical activity, while a steeper slope of the terrain related to better exercise capacity; (3) twelve-month completion of a behavioral physical activity intervention was determined by previous physical activity habits as well as interpersonal and environmental facilitators, while response to the intervention was related to diverse factors associated with motivation to change to an active lifestyle. Conclusions: This thesis shows that the natural progression of physical activity in COPD patients is heterogeneous and highlights that environmental, interpersonal and psychological factors are important determinants of physical activity behaviour in COPD patients, beyond clinical factors.
Antecedentes: Aunque la actividad física es clave para mejorar el pronóstico en pacientes con enfermedad pulmonar obstructiva crónica (EPOC), todavía no se dispone de información que permita adaptar las intervenciones de manera individualizada. El objetivo de la presente tesis es comprender la progresión de la actividad física y explorar sus determinantes en pacientes con EPOC. Métodos: Utilizamos datos basales y de seguimiento (12 meses) de 643 pacientes con EPOC estable de estadio leve a muy grave, procedentes de dos estudios europeos multicéntricos. Evaluamos: actividad física (Dynaport MoveMonitor), experiencia de actividad física (Clinical visit-PROactive physical activity in COPD [C-PPAC]), capacidad funcional de ejercicio (distancia caminada en la prueba de la marcha de 6 minutos [6MWD]) y variables sociodemográficas, interpersonales, ambientales, clínicas y psicológicas. Resultados: (1) La progresión natural de la actividad física a lo largo del tiempo fue heterogénea y se pudieron identificar tres patrones distintos: inactivo, activo que aumenta y activo que reduce. Mientras que el patrón de pacientes inactivo se relacionaba con peores características clínicas de la EPOC, no se pudo predecir la evolución de los activos a aumentar o reducir; (2) la mayor densidad de población y la exposición a largo plazo al NO2 se asociaron desfavorablemente con la actividad física, mientras que una mayor pendiente del terreno se relacionó con una mejor capacidad de ejercicio; (3) la compleción a los 12 meses con una intervención de actividad física conductual estuvo determinada por los hábitos de actividad física previos, así como por facilitadores interpersonales y ambientales, mientras que la respuesta a la intervención se relacionó con diversos factores asociados a la motivación para cambiar a un estilo de vida activo. Conclusiones: Esta tesis muestra que la progresión natural de la actividad física en los pacientes con EPOC es heterogénea y destaca que los factores ambientales, interpersonales y psicológicos son importantes determinantes de la actividad física en los pacientes con EPOC, más allá de los factores clínicos. Resum Antecedents: Malgrat el paper clau de l’activitat física per millorar el pronòstic en pacients amb malaltia pulmonar obstructiva crònica (MPOC), encara no disposem d’informació que permeti individualitzar les intervencions. L’objectiu d’aquesta tesi és entendre la progressió de l’activitat física i explorar-ne els determinants en pacients amb MPOC.
APA, Harvard, Vancouver, ISO, and other styles
7

Matsumoto, Takeshi. "Microalbuminuria in Patients with Obstructive Sleep Apnea-Chronic Obstructive Pulmonary Disease Overlap Syndrome." Kyoto University, 2018. http://hdl.handle.net/2433/232105.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Puhan, Milo Alan. "Patient-oriented research in chronic obstructive pulmonary disease /." Zürich, 2005. http://opac.nebis.ch/cgi-bin/showAbstract.pl?sys=000253399.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

McVeigh, Beverley. "An acute care program for patients with chronic obstructive pulmonary disease." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 2001. http://www.collectionscanada.ca/obj/s4/f2/dsk3/ftp04/MQ62030.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Baarends, Erica Maria. "Effort related energy expenditure in patients with chronic obstructive pulmonary disease." Maastricht : Maastricht : Universiteit Maastricht ; University Library, Maastricht University [Host], 1997. http://arno.unimaas.nl/show.cgi?fid=5924.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Chronic obstructive pulmonary disease patients"

1

Workshop "Respiratory Muscles in C.O.P.D." (1986 Montescano, Italy). Respiratory muscles in chronic obstructive pulmonary disease. London: Springer-Verlag, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

1948-, Ambrosino N., and Goldstein Roger, eds. Pulmonary rehabilitation. London: Hodder Arnold, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Parker, James N., and Philip M. Parker. The 2002 official patient's sourcebook on chronic obstructive pulmonary disease. Edited by Icon Group International Inc and NetLibrary Inc. San Diego, Calif: Icon Health Publications, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Carter, Rick. Courage and information for life with chronic obstructive pulmonary disease: The handbook for patients, families, and care givers managing COPD (emphysema, asthmatic bronchitis, or chronic bronchitis). Onset, MA: New Technology Pub., 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Shayevitz, Myra B. Living well with emphysema and bronchitis: A handbook for everyone with chronic obstructive pulmonary disease. Garden City, N.Y: Doubleday, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Newall, Clare. The effect of pulmonary rehabilitation and inspiratory muscle training in patients with chronic obstructive pulmonary disease and bronchiectasis. Birmingham: University of Birmingham, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

O'Brien, Christine. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Birmingham: University of Birmingham, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Woo, Kevin Y. The relationships between dyspnea, physical activity, and fatigue in patients with chronic obstructive pulmonary disease. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

K, Levine Stacie, and American Academy of Hospice and Palliative Medicine, eds. Unipac 9: Caring for patients with chronic illnesses : dementia, COPD, and CHF. 4th ed. Glenview, IL: American Academy of Hospice and Palliative Medicine, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kuncevskaya, Irina. Regenerative therapy of cerebral disorders in patients with chronic obstructive pulmonary disease at the stage of sanatorium rehabilitation. ru: INFRA-M Academic Publishing LLC., 2020. http://dx.doi.org/10.12737/1045706.

Full text
Abstract:
The monograph first presents modern concepts of comprehensive rehabilitation therapy of cerebral disorders in patients with chronic obstructive pulmonary disease at the stage of sanatorium rehabilitation. Using these data in the practice of medicine will improve the effectiveness of diagnostics, therapy and rehabilitation of cerebral disorders in patients with chronic obstructive pulmonary disease and to provide the students, residents, and graduate students of medical schools, neurologists, physiatrists, pulmonologists, internists, rehabilitation specialists, relevant professional competence. Designed for doctors, students and teachers of medical colleges and universities, and will also be useful for the system of training and retraining of medical workers.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Chronic obstructive pulmonary disease patients"

1

Bertholet, Renette, and Inessa McIntyre. "Chronic Obstructive Pulmonary Disease." In Patient Assessment in Clinical Pharmacy, 213–24. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-11775-7_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Shah, Shiwan K., Shawn P. E. Nishi, and Gulshan Sharma. "Chronic Obstructive Pulmonary Disease in Older Patients." In Aging and Lung Disease, 63–87. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-60761-727-3_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Milic-Emili, J., S. B. Gottfried, and A. Rossi. "Intrinsic PEEP and its ramifications in patients with respiratory failure." In Respiratory Muscles in Chronic Obstructive Pulmonary Disease, 141–48. London: Springer London, 1988. http://dx.doi.org/10.1007/978-1-4471-3850-1_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Schiavina, M. "Treatment of patients with respiratory failure during wakefulness and sleep: use of tank ventilator." In Respiratory Muscles in Chronic Obstructive Pulmonary Disease, 173–82. London: Springer London, 1988. http://dx.doi.org/10.1007/978-1-4471-3850-1_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hoth, Karin F., and Elizabeth Kozora. "Evaluating Cognition in Patients with Chronic Obstructive Pulmonary Disease." In Handbook on the Neuropsychology of Aging and Dementia, 661–74. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-93497-6_39.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kozora, Elizabeth, and Karin F. Hoth. "Evaluating Cognition in Patients with Chronic Obstructive Pulmonary Disease." In Handbook on the Neuropsychology of Aging and Dementia, 455–66. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-3106-0_28.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Gözükirmizi, E., N. Yildirim, H. Kaynak, S. Madazlioğlu, H. Denktas, and F. Yenel. "Polysomnographic Findings in Patients with Chronic Obstructive Pulmonary Disease (COPD)." In Control of Breathing During Sleep and Anesthesia, 49–53. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4757-9850-0_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Folgering, H., P. Vos, Y. Heijdra, M. Wagenaar, and C. v. Herwaarden. "Sleep disordered breathing in patients with chronic obstructive pulmonary disease." In Physiology And Pharmacology of Cardio-Respiratory Control, 51–58. Dordrecht: Springer Netherlands, 1998. http://dx.doi.org/10.1007/978-94-011-5129-0_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Zhu, Zhi-hua, Tao Liu, Bo Cong, and Fengping Liu. "A Pulmonary Rehabilitation Training Robot for Chronic Obstructive Pulmonary Disease Patient." In Wearable Sensors and Robots, 251–62. Singapore: Springer Singapore, 2016. http://dx.doi.org/10.1007/978-981-10-2404-7_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kumar, Saurabh, and Suchit Swaroop. "Collateral Development of Invasive Pulmonary Aspergillosis (IPA) in Chronic Obstructive Pulmonary Disease (COPD) Patients." In Fungal Biology, 111–18. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-18586-2_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Chronic obstructive pulmonary disease patients"

1

Walid, Feki, Chaabouni Malek, Ketata Wajdi, Moussa Nadia, Bahloul Najla, Msaad Sameh, Kotti Amina, et al. "Chronic pain in patients with chronic obstructive pulmonary disease." In ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa4012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gupta, V., D. Singh, S. Pandit, P. Bhadoria, and D. P. Bhadoria. "Prevalence of Asthma Chronic Obstructive Pulmonary Disease Overlap Syndrome in Indian Patients of Chronic Obstructive Pulmonary Disease." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4746.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Zaghla, Hanan, Hatem Al Atroush, Ahmed Samir, and Mohamed Kamal. "Arrhythmias in Patients with Chronic Obstructive Pulmonary Disease." In Annual International Conference on Cardiology & Cardiovascular Medicine Research. Global Science & Technology Forum (GSTF), 2013. http://dx.doi.org/10.5176/2382-5669_ccmr13.26.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Udrescu, Lucretia, Laura Sbarcea, and Stefan Mihaicuta. "Cardiovascular comorbidities in chronic obstructive pulmonary disease patients." In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa3607.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bossios, Apostolos, Linda Ekerljung, Minna Turkkila, Carina Malmhäll, Malin Erlandsson, Sofia Töyra Silfverswärd, Bo Lundbäck, and Maria Bokarewa. "Survivin in patients with chronic obstructive pulmonary disease." In Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa3347.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Guimaraes, V. A., K. S. Correa, and M. F. Rabahi. "Chronic Obstructive Pulmonary Disease Plus (COPD+)® as a Friendly App for Patients with Chronic Obstructive Pulmonary Disease." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4830.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Mirdamadi, Mahsa, Hosnollah Sadeghi, Ali Safaei, and Mahmood Salesi. "Postoperative Pulmonary Complications in Bronchial Asthma/Chronic Obstructive Pulmonary Disease/Non-Pulmonary Disease Patients." In ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa4061.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ziherl, K., I. Sarc, T. Jeric, M. Kosnik, S. Suskovic, SD Anker, and M. Lainscak. "Renal Function in Patients with Chronic Obstructive Pulmonary Disease." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a1456.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Waschki, B., H. Watz, G. Kretschmar, A. Kirsten, T. Meyer, and H. Magnussen. "Physical Activity in Patients with Chronic Obstructive Pulmonary Disease." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a1545.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Tavares, Joana, Ana Raquel Cruz, and Rui Nogueira. "Chronic Obstructive Pulmonary Disease – Are We Vaccinating the Patients?" In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa673.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Chronic obstructive pulmonary disease patients"

1

Czerwaty, Katarzyna, Karolina Dżaman, Krystyna Maria Sobczyk, and Katarzyna Irmina Sikrorska. The Overlap Syndrome of Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease: A Systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2022. http://dx.doi.org/10.37766/inplasy2022.11.0077.

Full text
Abstract:
Review question / Objective: To provide the essential findings in the field of overlap syndrome of chronic obstructive pulmonary disease and obstructive sleep apnea, including prevalence, possible predictors, association with clinical outcomes, and severity compared to both chronic obstructive pulmonary disease and obstructive sleep apnea patients. Condition being studied: OSA is characterized by complete cessation (apnea) or significant decrease (hy-popnea) in airflow during sleep and recurrent episodes of upper airway collapse cause it during sleep leading to nocturnal oxyhemoglobin desaturations and arousals from rest. The recurrent arousals which occur in OSA lead to neurocognitive consequences, daytime sleepiness, and reduced quality of life. Because of apneas and hypopneas, patients are experiencing hypoxemia and hypercapnia, which result in increasing levels of catecholamine, oxidative stress, and low-grade inflammation that lead to the appearance of cardio-metabolic consequences of OSA. COPD is a chronic inflammatory lung disease defined by persistent, usually pro-gressive AFL (airflow limitation). Changes in lung mechanics lead to the main clini-cal manifestations of dyspnea, cough, and chronic expectoration. Furthermore, patients with COPD often suffer from anxiety and depression also, the risk of OSA and insomnia is higher than those hospitalized for other reasons. Although COPD is twice as rare as asthma but is the cause of death eight times more often.
APA, Harvard, Vancouver, ISO, and other styles
2

Barros-Poblete, Marisol, Rodrigo Torres-Castro, Mauricio Henríquez, Anita Guequen, Isabel Blanco, and Carlos Flores. Dysbiosis as a prognostic factor for clinical worsening in chronic respiratory disease: A systematic review and metanalysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0089.

Full text
Abstract:
Review question / Objective: Is dysbiosis a prognostic factor for clinical worsening in patients with chronic respiratory diseases?. Condition being studied: Dysbiosis, defined as changes in the quantitative and qualitative composition of the microbiota. Eligibility criteria: Over 18 years old adult patients with chronic respiratory diseases clinical diagnosis (cystic fibrosis, chronic obstructive pulmonary disease, asthma, idiopathic pulmonary fibrosis, interstitial lung disease, sarcoidosis, bronchiectasis, non-CF bronchiectasis, pulmonary hypertension) according to the International Statistical Classification of Diseases and Related Health Problems (ICD) from OMS) and international guidelines of each disease.
APA, Harvard, Vancouver, ISO, and other styles
3

Liang, R., D. Liu, HB Li, and ZG Zhai. The efficacy and safety of traditional Chinese medicine formulas in the treatment of chronic obstructive pulmonary disease complicated with pulmonary hypertension: a systematic review and meta-analysis study. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, October 2022. http://dx.doi.org/10.37766/inplasy2022.10.0041.

Full text
Abstract:
Review question / Objective: This systematic review and meta-analysis was intended to evaluate the efficacy and safety of traditional Chinese medicine(TCM) formulas in the treatment of chronic obstructive pulmonary disease(COPD) complicated with pulmonaryhypertension (PH). Condition being studied: Chronic obstructive pulmonary disease(COPD) complicated with pulmonary hypertension(PH) is classified as the third group PH.According to epidemiology, the most common cause of PH associated with lung diseases and/or hypoxia is COPD, but the prevalence rate of COPD with PH range from 20% to 91% variously. In China, many TCM formulas are regularly used in COPD patients , thus TCM formulas therapy is worth considering.
APA, Harvard, Vancouver, ISO, and other styles
4

Liu, Lu, Wenchuan Qi, Qian Zeng, Ziyang Zhou, Daohong Chen, Lei Gao, Bin He, Dingjun Cai, and Ling Zhao. Does acupuncture improve lung function in chronic obstructive pulmonary disease animal model?: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2022. http://dx.doi.org/10.37766/inplasy2022.3.0104.

Full text
Abstract:
Review question / Objective: Chronic obstructive pulmonary disease (COPD) is a common, preventable, and treatable disease characterized by persistent respiratory symptoms and progressive airflow obstruction documented on spirometry. Acupuncture, as a safe and economical non-pharmacology therapy, has pronounced therapeutic effects in COPD patients. Several systematic reviews draw the conclusion that acupuncture could improve patients’ quality of life, exercise capacity and dyspnoea, however, the results about lung function were inconclusive. Recently, increasing number of animal studies has been published to illustrate the effects of acupuncture in improving lung function in COPD animal model. However, the efficacy of acupuncture for experimentally induced COPD have not been systematically investigated yet. A systematic review of animal experiments can benefit future experimental designs, promote the conduct and report of basic researches and provide some guidance to translate the achievements of basic researches to clinical application in acupuncture for COPD. Therefore, we will conduct this systematic review and meta-analysis to evaluate effects of acupuncture on COPD animal model.
APA, Harvard, Vancouver, ISO, and other styles
5

Guo, Zhaohui, Peng Wang, shali Qiu, Xiang Wang, and Xing Wang. Bayesian network meta-analysis of intervention effect of traditional Chinese sports in patients with stable chronic obstructive pulmonary disease. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2023. http://dx.doi.org/10.37766/inplasy2023.1.0011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Li, Xindan, Hongyan Lu, Xiaona Zhang, Jie Zhao, Xiangkan Feng, Yan Chang, Rui Zhang, and Zhenzhen Wu. Prevalence of urinary incontinence in patients with chronic obstructive pulmonary disease:A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2021. http://dx.doi.org/10.37766/inplasy2021.5.0037.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

xu, lingxia, qing tu, dongmei yan, bin li, peng sun, and fei wang. Efficacy of shenqi bufei decoction on stable chronic obstructive pulmonary disease patients: A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0069.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

DePriest, Jack. Work of Breathing as a Predictor of Failure to Wean from Mechanical Ventilation in Patients with Severe Chronic Obstructive Pulmonary Disease. Fort Belvoir, VA: Defense Technical Information Center, May 1993. http://dx.doi.org/10.21236/ada268432.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

DePriest, Jack. Work of Breathing as a Predictor of Failure to Wean from Mechanical Ventilation in Patients with Severe Chronic Obstructive Pulmonary Disease. Fort Belvoir, VA: Defense Technical Information Center, November 1993. http://dx.doi.org/10.21236/ada274121.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Feng, XinYu, and YuLan Zeng. Effects of Pseudomonas aeruginosa infection on the prognosis of patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2021. http://dx.doi.org/10.37766/inplasy2021.4.0092.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Chronic obstructive pulmonary disease patients' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography